SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a number one insulin supply and diabetes expertise firm, right this moment introduced a brand new Tandem Mobi consumer satisfaction and wearability survey Actual world insights. The survey discovered that 86% of individuals had been glad or very glad with Tandem Mobi, no matter earlier therapy, and agreed that Tandem Mobi helped enhance their high quality of life. (AID) system, turning into the world’s smallest and most sturdy automated insulin supply (AID) system, shall be launched in america in February 2024.
“These real-world consumer insights present proof that we’re additional advancing our mission of bettering the lives of individuals with diabetes by demonstrating that Tandem Mobi not solely meets however exceeds consumer expectations,” stated Jordan Pinsker, MD, chief medical officer of Tandem Diabetes Care. ). We’re proud to share these outcomes on the ADA and can proceed to innovate to offer choices and enhance high quality of life for the diabetes neighborhood.
Within the six-week restricted launch survey, early customers who had beforehand used a number of each day injections (MDI), different insulin pumps (tube and tubeless), or had been former Tandem pump customers additionally expressed optimistic suggestions about Tandem. Mobi’s distinctive put on resistance demonstrates excessive satisfaction mixed with the Management-IQ algorithm. Tandem Mobi is sufficiently small to hold nearly anywhere2, giving the consumer better freedom, consolation and suppleness. In the meantime, Management-IQ expertise anticipates and helps stop the highs and lows.
Earlier MDI customers:
- 84% stated Tandem Mobi lowered the burden of managing diabetes
- 82% stated Tandem Mobi was simple to make use of
- 77% stated Tandem Mobi made them really feel freer in life
Earlier pump customers:
- 78% stated Tandem Mobi lowered the burden of managing diabetes
- 88% stated Tandem Mobi was simple to make use of
- 80% of individuals stated Tandem Mobi made them really feel freer in life
Barbara Davis Heart for Early Adopter Analysis
ADA additionally shared insights from an unbiased research involving Tandem Mobi customers. The outcomes confirmed that point inside vary improved, whereas time under vary didn’t enhance. For youthful individuals, kind, portability, discreteness, and wearability had been important to satisfaction and continued use. Tandem Mobi provides a wide range of choices to fulfill the wants of teenagers with kind 1 diabetes, together with:
- Minimal fill dimension (30 models) – reduces insulin waste for customers with low insulin wants
- Fast bolus button on bodily pump – easy, discreet bolus, programmable in gram or unit increments
- Matches snugly and comes with light-weight adhesive sleeve and 5-inch tube (each bought individually)
- Private, iPhone-compatible management
The Product Theater has been recorded and shall be obtainable on the ADA web site for registered attendees after the convention and on the Tandem web site at tandemdiabetes.com/suppliers/occasions.
|
1 |
Till June 2024. |
|
2 |
The pump shouldn’t be positioned greater than 12 inches (30.5 cm) above the infusion web site. Doing so could lead to overdelivery of insulin. |
|
3 |
Up to now, all printed scientific trials and real-world research of Management-IQ expertise have been primarily based on using the Dexcom (NASDAQ: ) G6 CGM with the Tandem t:slim X2 insulin pump. |
About Tandem Diabetes Care
Tandem Diabetes Care is a world insulin supply and diabetes expertise firm that manufactures and markets superior automated insulin supply techniques that scale back the burden of diabetes administration whereas creating new prospects for sufferers, their family members and healthcare suppliers. The corporate’s pump portfolio contains the Tandem Mobi system and the t:slim X2 insulin pump, each of which characteristic Management-IQ’s superior hybrid closed-loop expertise. Tandem Diabetes Care Heart is situated in San Diego, California. For extra info, go to tandemdiabetes.com.
Observe Tandem Diabetes Care on the X @tandemdiabetes; use #tslimX2 #TandemMobi and #TandemDiabetes.
Observe Tandem Diabetes Care on Fb (NASDAQ:) www.fb.com/TandemDiabetes.
Observe Tandem Diabetes Care on LinkedIn: https://www.linkedin.com/firm/tandemdiabetes.
© 2024 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, the Tandem emblem, Management-IQ, t:slim X2 and Tandem Mobi are emblems of Tandem Diabetes Care, Inc. in america and/or different nations. All third-party emblems are the property of their respective homeowners.
Use Management-IQ expertise responsibly
Management-IQ expertise can’t stop all of the highs and lows. Customers should nonetheless complement their food plan and actively handle their diabetes. Please go to tandemdiabetes.com/responsible-use for extra necessary safety info.
Vital security info
Obtain solely. Directions to be used: tandem cellular system: The Tandem Mobi insulin pump (pump) with interoperable expertise is designed to ship insulin subcutaneously at set and variable charges for the therapy of diabetes in individuals who require insulin. The pump reliably and securely communicates with suitable digitally related gadgets, together with automated insulin supply software program, to obtain, execute and acknowledge instructions from these gadgets. The pump is for single-patient dwelling use and requires a prescription. This pump is appropriate for ages 6 and up. t:Extremely-thin X2 insulin pump: The t:slim X2 insulin pump with interoperable expertise is designed to ship insulin subcutaneously at set and variable charges for the therapy of diabetes in individuals who require insulin. The pump reliably and securely communicates with suitable digitally related gadgets, together with automated insulin supply software program, to obtain, execute and acknowledge instructions from these gadgets. This pump is for single affected person use. This pump is appropriate for NovoLog or Humalog U-100 insulin. This pump is appropriate for ages 6 and up. Management-IQ Know-how: Management-IQ expertise is designed to be used with a suitable built-in steady glucose monitor (iCGM, bought individually) and an Alternate Controller Enabled (ACE) pump to routinely enhance, lower, and Suspension of basal insulin supply. It will probably additionally present a correction bolus when predicted glucose values ​​exceed a predefined threshold. Management-IQ expertise is designed for the administration of Kind 1 diabetes in folks 6 years of age and older. Management-IQ expertise is for single affected person use. Management-IQ expertise is obtainable with NovoLog or Humalog U-100 insulin.
WARNING: Management-IQ expertise shouldn’t be utilized by anybody beneath 6 years of age. It also needs to not be utilized in sufferers who require lower than 10 models of insulin per day or who weigh lower than 55 kilos.
Management-IQ expertise isn’t meant to be used by pregnant ladies, dialysis sufferers, or critically ailing sufferers. Don’t use Management-IQ Know-how if utilizing hydroxyurea. Customers of Tandem insulin pumps and Management-IQ expertise should use the insulin pump, CGM, and all different system elements in accordance with their respective directions to be used; take a look at blood glucose ranges as advisable by their healthcare supplier; reveal sufficient carbohydrate counting expertise; keep Satisfactory diabetes self-care expertise; see a well being care supplier usually; and have sufficient imaginative and prescient and/or listening to to acknowledge all pump capabilities, together with alarms, alerts, and reminders. Earlier than performing MRI, CT or diathermy therapy, the sequence pump and CGM transmitter and sensor have to be eliminated. Please go to tandemdiabetes.com/safetyinfo for extra necessary security info.
View supply model on businesswire.com: https://www.businesswire.com/information/dwelling/20240622672597/en/
Media contact info:
858-366-6900
media@tandemdiabetes.com
Investor contact info:
858-366-6900
IR@tandemdiabetes.com
Supply: Tandem Diabetes Care, Inc.
